Literature DB >> 23913227

Establishment of primary cultures from ovarian tumor tissue and ascites fluid.

Brigitte L Thériault1, Lise Portelance, Anne-Marie Mes-Masson, Mark W Nachtigal.   

Abstract

We have refined the technique for isolating and propagating cultures of primary epithelial ovarian cancer (EOC) cells derived from solid tumors and ascites. Both protocols involve a simple yet rapid method for the growth and propagation of EOC tumor and ascites cells in a basal culture medium without the addition of growth factors. Isolation of tumor EOC cells involves the mechanical disruption of the tumor tissue with the help of a cell scraper, while ascites-derived EOC cells are mixed with growth medium and placed directly into culture with very little manipulation. We further describe a partial trypsinization method to eliminate fibroblast contamination from primary EOC cells derived from solid tumors. These methods allow for the direct application of many molecular, cellular, and functional analyses within a few weeks of initial isolation, with the added potential of retrospective analyses of archived cells and tissues. Thus, we have included steps for long-term cryopreservation of early-passage EOC cells. Initial isolation of EOC cells can be completed within 1 h, and primary cells are further expanded in culture for several weeks.

Entities:  

Mesh:

Year:  2013        PMID: 23913227     DOI: 10.1007/978-1-62703-547-7_24

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

1.  Doxorubicin synergizes with 34.5ENVE to enhance antitumor efficacy against metastatic ovarian cancer.

Authors:  Chelsea Bolyard; Ji Young Yoo; Pin-Yi Wang; Uksha Saini; Kellie S Rath; Timothy P Cripe; Jianying Zhang; Karuppaiyah Selvendiran; Balveen Kaur
Journal:  Clin Cancer Res       Date:  2014-10-07       Impact factor: 12.531

2.  AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancer.

Authors:  David Pépin; Amanda Sosulski; Lihua Zhang; Dan Wang; Vinod Vathipadiekal; Katherine Hendren; Caroline M Coletti; Aaron Yu; Cesar M Castro; Michael J Birrer; Guangping Gao; Patricia K Donahoe
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-27       Impact factor: 11.205

Review 3.  Modeling platinum sensitive and resistant high-grade serous ovarian cancer: development and applications of experimental systems.

Authors:  Paula Cunnea; Euan A Stronach
Journal:  Front Oncol       Date:  2014-04-17       Impact factor: 6.244

4.  The role of KIF14 in patient-derived primary cultures of high-grade serous ovarian cancer cells.

Authors:  Brigitte L Thériault; Paulina Cybulska; Patricia A Shaw; Brenda L Gallie; Marcus Q Bernardini
Journal:  J Ovarian Res       Date:  2014-12-21       Impact factor: 4.234

5.  Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies.

Authors:  Hanni Uusi-Kerttula; James Davies; Lynda Coughlan; Sarah Hulin-Curtis; Rachel Jones; Louise Hanna; John D Chester; Alan L Parker
Journal:  Oncotarget       Date:  2016-05-10

6.  Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells.

Authors:  Amani I Moraya; Jennifer L Ali; Pranati Samadder; Lisa Liang; Ludivine Coudière Morrison; Tamra E Werbowetski-Ogilvie; Makanjuola Ogunsina; Frank Schweizer; Gilbert Arthur; Mark W Nachtigal
Journal:  J Exp Clin Cancer Res       Date:  2017-05-12

7.  The temporal dynamics of chromosome instability in ovarian cancer cell lines and primary patient samples.

Authors:  Signe Penner-Goeke; Zelda Lichtensztejn; Megan Neufeld; Jennifer L Ali; Alon D Altman; Mark W Nachtigal; Kirk J McManus
Journal:  PLoS Genet       Date:  2017-04-04       Impact factor: 5.917

8.  CAISMOV24, a new human low-grade serous ovarian carcinoma cell line.

Authors:  Rodrigo Fernandes da Silva; Daniela Maira Cardozo; Gisele Olinto Libanio Rodrigues; Caroline Natânia de Souza-Araújo; Natacha Azussa Migita; Liliana Aparecida Lucci de Angelo Andrade; Sophie Derchain; José Andrés Yunes; Fernando Guimarães
Journal:  BMC Cancer       Date:  2017-11-13       Impact factor: 4.430

Review 9.  Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications.

Authors:  Hanni Uusi-Kerttula; Sarah Hulin-Curtis; James Davies; Alan L Parker
Journal:  Viruses       Date:  2015-11-24       Impact factor: 5.048

10.  Three-Dimensional Cell Culture Based on Magnetic Fields to Assemble Low-Grade Ovarian Carcinoma Cell Aggregates Containing Lymphocytes.

Authors:  Caroline Natânia de Souza-Araújo; Cláudia Rodrigues Tonetti; Marcella Regina Cardoso; Liliana Aparecida Lucci de Angelo Andrade; Rodrigo Fernandes da Silva; Luís Gustavo Romani Fernandes; Fernando Guimarães
Journal:  Cells       Date:  2020-03-06       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.